Last 23 quarters of trend data · Technology · Software - Infrastructure
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Cellebrite DI Ltd.'s quarterly P/E stands at 79.4x, up 14.4% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has compressed 34.8% YoY to 52.1x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 40.06 | 79.38 | 53.34 | 57.33 | 51.15 | 69.39 | 70.70 | — | — | — | — | 60.14 | — |
| — | +14.4% | -24.5% | — | — | — | — | — | — | — | — | +697.8% | — | |
| P/S Ratio | 6.51 | 6.77 | 8.80 | 9.18 | 8.79 | 11.26 | 12.49 | 8.22 | 6.21 | 6.09 | 4.53 | 4.64 | 4.42 |
| — | -39.9% | -29.6% | +11.6% | +41.6% | +85.0% | +176.0% | +77.1% | +40.6% | +52.8% | +59.4% | +75.8% | +12.2% | |
| P/B Ratio | 6.41 | 6.80 | 9.36 | 10.34 | 9.75 | 13.33 | 16.22 | 11.78 | — | — | 49.22 | 41.21 | 77.16 |
| — | -48.9% | -42.3% | -12.3% | — | — | -67.1% | -71.4% | — | — | +332.5% | +223.6% | +88.4% | |
| P/FCF | 19.89 | 51.56 | 14.48 | 38.63 | 34.37 | 65.32 | 22.10 | 22.06 | 48.87 | 68.83 | 10.83 | 13.91 | 21.50 |
| — | -21.1% | -34.5% | +75.1% | -29.7% | -5.1% | +104.1% | +58.6% | +127.3% | +176.9% | +67.8% | — | — | |
| EV / EBITDA | 38.24 | 52.14 | 44.78 | 50.33 | 56.25 | 79.94 | 71.37 | 38.41 | 37.88 | 43.42 | 21.41 | 22.68 | 43.72 |
| — | -34.8% | -37.2% | +31.0% | +48.5% | +84.1% | +233.3% | +69.4% | -13.4% | -57.3% | +35.9% | -83.5% | — | |
| EV / EBIT | 45.07 | 92.19 | 24.34 | 57.50 | 34.25 | 97.08 | — | 43.59 | 45.69 | 56.00 | — | 26.68 | 68.01 |
| — | -5.0% | — | +31.9% | -25.0% | +73.4% | — | +63.4% | -32.8% | -97.1% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cellebrite DI Ltd.'s operating margin was 7.1% in Q1 2026, down 9.0 pp QoQ and down 4.3 pp YoY. The trailing four-quarter average of 12.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.2% | 82.5% | 84.7% | 83.9% | 84.4% | 83.7% | 83.8% | 85.5% | 83.0% | 85.2% | 84.0% | 84.7% | 83.0% |
| — | -1.4% | +1.0% | -1.9% | +1.7% | -1.7% | -0.1% | +1.0% | +0.0% | +3.2% | +0.4% | +6.2% | +5.0% | |
| Operating Margin | 14.0% | 7.1% | 16.2% | 15.1% | 12.7% | 11.4% | 14.4% | 18.2% | 13.0% | 10.3% | 16.1% | 16.0% | 6.0% |
| — | -37.7% | +12.0% | -17.2% | -2.4% | +10.5% | -10.6% | +13.6% | +116.4% | +5307.2% | +23.4% | +1157.8% | +167.4% | |
| Net Margin | 16.5% | 8.5% | 16.5% | 16.0% | 17.2% | 16.2% | 17.7% | -193.8% | -24.9% | -79.7% | -15.7% | 7.7% | -42.2% |
| — | -47.3% | -6.6% | +108.3% | +169.1% | +120.3% | +212.2% | -2609.9% | +41.0% | -39.8% | -264.7% | -77.9% | -179.5% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 19.1% | 2.2% | 4.6% | 4.7% | 5.0% | 5.0% | 6.1% | -160.4% | — | -1901.7% | -40.6% | 23.4% | -113.7% |
| — | -55.8% | -24.9% | +102.9% | — | +100.3% | +115.0% | -784.9% | — | -2551.4% | -482.4% | -61.0% | -120.3% | |
| ROA | 9.6% | 1.2% | 2.4% | 2.5% | 2.6% | 2.5% | 2.9% | -34.9% | -4.4% | -13.4% | -2.9% | 1.4% | -7.7% |
| — | -53.4% | -17.9% | +107.1% | +159.3% | +118.5% | +200.7% | -2525.7% | +43.1% | -35.1% | -254.9% | -80.6% | -175.5% | |
| ROIC | 18.5% | 1.7% | 5.5% | 6.5% | 4.0% | 4.2% | 7.2% | 75.2% | — | — | — | — | — |
| — | -58.3% | -23.6% | -91.4% | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Cellebrite DI Ltd.'s Debt/EBITDA ratio is 1.4x, up from 0.9x last quarter — comfortably within a safe range. The current ratio has weakened 16.0% YoY to 1.53x, tightening the short-term liquidity position. Debt/Equity has declined for 4 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.03 | 0.03 | 0.04 | — | — | 0.41 | 0.32 | 0.77 |
| — | +53.1% | +43.4% | +16.4% | — | — | -92.1% | -87.0% | — | — | +98.7% | — | — | |
| Debt / EBITDA | 0.29 | 1.41 | 0.92 | 0.99 | 1.31 | 0.71 | 0.59 | 0.56 | 0.78 | 1.09 | 0.80 | 0.76 | 1.89 |
| — | +98.7% | +54.1% | +77.7% | +69.4% | -34.5% | -25.9% | -26.6% | -59.0% | -81.1% | -36.3% | — | — | |
| Current Ratio | 1.56 | 1.53 | 1.56 | 2.11 | 1.96 | 1.82 | 1.92 | 1.84 | 1.75 | 1.59 | 1.66 | 1.65 | 1.65 |
| — | -16.0% | -18.9% | +14.8% | +11.8% | +14.4% | +15.5% | +11.3% | +6.0% | +4.9% | +16.8% | +19.3% | +22.1% | |
| Quick Ratio | 1.54 | 1.51 | 1.54 | 2.08 | 1.92 | 1.79 | 1.89 | 1.80 | 1.71 | 1.55 | 1.62 | 1.60 | 1.60 |
| — | -15.7% | -18.7% | +15.5% | +12.5% | +15.3% | +16.4% | +12.6% | +7.2% | +6.2% | +18.1% | +20.0% | +22.4% | |
| Interest Coverage | — | — | — | — | — | — | — | 0.09 | 0.36 | 0.12 | — | 2.03 | 0.13 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CLBT stock.
Cellebrite DI Ltd.'s current P/E is 40.1x. The average P/E over the last 4 quarters is 60.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cellebrite DI Ltd.'s current operating margin is 14.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cellebrite DI Ltd.'s business trajectory between earnings reports.